Mini-Symposium Inflammatory Skin Disease

Human inflammatory skin diseases encompass a range of conditions characterized by inflammation, redness, and irritation of the skin. Common examples include psoriasis, atopic dermatitis (eczema), and contact dermatitis. These diseases can result from a combination of genetic, environmental, and immunological factors, leading to an overactive immune response. Symptoms often include itching, scaling, and discomfort, significantly affecting patients' quality of life. Effective management typically involves a combination of topical treatments, systemic medications, and lifestyle modifications.

These conditions affect millions of people worldwide, significantly impacting their quality of life and mental well-being. Understanding the underlying mechanisms of inflammation therefore is crucial to help identify potential therapeutic targets and to develop more effective treatments. Moreover, such research aids in uncovering genetic, environmental, and immunological factors that contribute to disease onset and progression. As our understanding deepens, we can better address the needs of affected individuals.

It is thus with immense pleasure that we announce a mini-symposium of one afternoon, on Thursday, November 28, in which some of the leading researchers in this field will share their latest findings. The detailed program for the afternoon is given below. The event will take place in the "Kleine Aula" (i.e. RAA-G-01) of the University of Zurich, at the Rämistrasse 59.

The event is public, but to avoid food waste, we kindly ask for a registration to attend. Update: Registration is closed.

 

Information flyer of the mini-symposium Inflammatory Skin Disease

 

Program


Thursday, November 28, 2024

MINI-SYMPOSIUM
Inflammatory Skin Disease
13:30 Lukas Sommer • University of Zurich
Welcome address
13:35 Liv Eidsmo • Karolinska Institute
How can we help the skin forget?
Local and systemic replenishment of resident T cells in human skin
14:15 Luca Ferrarese • ETH Zurich
The role of keratinocyte growth factor (KGF/FGF7) signaling in skin inflammation
14:35 Lars French • LMU Munich
Inflammatory skin diseases — break-through technologies to address unmet needs
15:15 Stefanie Schärli • University of Bern
IL-9 sensitizes human TH2 cells to pro-inflammatory IL-18 signals in atopic dermatitis

15:35    —    16:20 • Coffee break

16:20 Sara Brown • University of Edinburgh
Molecular genetic studies to understand atopic dermatitis
17:00 Michela Di Filippo • University of Zurich
NLRP1 inflammasome activation in skin equivalents reveals mechanistic insights into the roles of keratinocytes in psoriasis
17:20 Kilian Eyerich • University of Freiburg
The interaction of adaptive immune cells and resident epithelial cells in inflammatory skin diseases
18:00 Sabine Werner • ETH Zurich
Closing words